Johnson & Johnson Is Walking Away From a $100 Billion Obesity Market. Could That Actually Make It the Better Long-Term Buy Than Eli Lilly?
2026-07-03 21:35:00 ET Eli Lilly (NYSE: LLY) is a Wall Street darling thanks to its success in th
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.